News
12-08-2011, 04:41 AM
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
More... (http://www.news-medical.net/news/20111208/Combination-of-two-anti-estrogen-drugs-extends-survival-time-of-women-with-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20111208/Combination-of-two-anti-estrogen-drugs-extends-survival-time-of-women-with-breast-cancer.aspx)